Primary Recipient

THERALOGICS,INC

Amount

$234,764.00

Award Date

8/01/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.726

CDFA Program Title

ARRA Accelerating Adoption of Comparative Effectiveness Research (CER)

Description

This supplemental proposal investigates a new compound that can block the white cells that cause Graft vs. Host Disease (GVHD) and the proteins that cause the symptoms associated with GVHD.

Recipients Connected to Award

Recipient	Role	Amount
THERALOGICS,INC	Primary recipient	$186,698.00
FRED HUTCHINSON CANCER RESEARCH CENTER	Sub-recipient	$48,066.00